RNA based vaccine · VDDBV0193
Note: 5 additional source trials listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.
| NCT ID | Phase | Disease / Condition |
|---|---|---|
| NCT04449276 | Phase 1 | COVID-19 |
| NCT04515147 | Phase 2 | COVID-19 |
| NCT04652102 | Phase 3 | COVID-19 |
| NCT04674189 | Phase 3 | COVID-19 |
| NCT04838847 | Phase 3 | COVID-19 |
| NCT04860258 | Phase 3 | COVID-19 |